Article Details
Retrieved on: 2024-10-15 23:48:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Jefferies Financial Group boosted their price objective on shares of Arbutus Biopharma from $5.00 to $7.00 and gave the stock a "buy" rating in a ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here